CAP TODAY Webinars

Webinar presenters Melanie Pollan, PhD, Alan H. B. Wu, PhD, and Christopher DeFilippi, MD, discuss how the Atellica IM TnIH assay can be used to aid in offering rapid and accurate detection of AMI, helping lead to a faster diagnosis (versus contemporary Troponin assays); it can now also assist clinicians to identify future death and cardiovascular event risk based on the new prognosis indication for use.

Webinar presenters Gwen Clarke, MD, FRCPC, Hematopathology and Transfusion Medicine, Island Health, Victoria British Columbia Canada, and Clinical Professor, Department of Laboratory Medicine Pathology, University of Alberta, and Nancy Robitaille, MD, FRCPC, Vice-President, Transfusion Medicine, Héma-Québec, Montreal Canada Hematology-Oncology, CHU Sainte-Justine, Montreal, Canada and Clinical Professor, Department of Pediatrics, Université de Montréal discuss how advancements in non-invasive prenatal testing (NIPT) for fetal RHD are transforming targeted antenatal prophylaxis with RhIG.

Webinar presenter Pranil K. Chandra, DO, Senior Vice President, Chief Genomics Officer, PathGroup, explores pathogenic gene fusions as oncogenic drivers and actionable biomarkers in precision oncology, focusing on NRG1 fusions.

Webinar presenters Marilyn M. Bui, MD, PhD, FCAP, Professor of Pathology and Scientific Director of Analytic Microscopy Core, Moffitt Cancer Center, and Savitri Krishnamurthy, MD, Professor, Department of Pathology, The University of Texas MD Anderson Cancer Center, and Patricia M. Raciti, MD, Scientific Director, Early Clinical Development and Translational Research, J&J Innovative Medicine, and Sylvia L. Asa, MD, PhD, Consultant in Endocrine Pathology, University Hospitals Cleveland Medical Center, Professor of Pathology, Case Western Reserve University discuss evaluation and implementation of AI tools for clinical use.

Webinar presenters Pranil K. Chandra, DO, Senior Vice President, Chief Genomics Officer PathGroup, and Nayan J. Sarma, PhD, HCLD/CC (ABB), Associate Director of Molecular Oncology PathGroup, and Jeff Gregg, MD, Vice President Medical Affairs, Biofidelity, Professor of Pathology and Laboratory Medicine, University of Nevada School of Medicine, address the gaps and limitations of CGP by using innovative simplified genomic profiling solutions that work for challenging samples not analyzable by CGP.